Summary

The global Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.
With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.
Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.
The global Nicotinamide Mononucleotide (NMN) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation
By Company:
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical
By Type: (Dominant Segment vs High-Margin Innovation)
Content ≥98%
Content ＜98%
By Application: (Core Demand Driver vs Emerging Opportunity)
Health Care Products
Cosmetics
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GeneHarbor in Europe)
- Emerging Product Trends: Content ≥98% adoption vs. Content ＜98% premiumization
- Demand-Side Dynamics: Health Care Products growth in China vs. Cosmetics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
China
Japan
(Additional regions can be customized based on client needs.)

Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Nicotinamide Mononucleotide (NMN) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Content ＜98% in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cosmetics in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Nicotinamide Mononucleotide (NMN) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Nicotinamide Mononucleotide (NMN) Product Scope
1.2 Nicotinamide Mononucleotide (NMN) by Type
1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2020 & 2024 & 2031)
1.2.2 Content ≥98%
1.2.3 Content ＜98%
1.3 Nicotinamide Mononucleotide (NMN) by Application
1.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Nicotinamide Mononucleotide (NMN) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Nicotinamide Mononucleotide (NMN) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Nicotinamide Mononucleotide (NMN) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Nicotinamide Mononucleotide (NMN) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025)
2.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
2.3 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031)
2.4.2 China Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031)
2.4.3 Japan Nicotinamide Mononucleotide (NMN) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Review by Type (2020-2025)
3.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2025)
3.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2025)
3.1.3 Global Nicotinamide Mononucleotide (NMN) Price by Type (2020-2025)
3.2 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2026-2031)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2026-2031)
3.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2026-2031)
3.3 Different Types Nicotinamide Mononucleotide (NMN) Representative Players
4 Global Market Size by Application
4.1 Global Nicotinamide Mononucleotide (NMN) Historic Market Review by Application (2020-2025)
4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2025)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2025)
4.1.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2020-2025)
4.2 Global Nicotinamide Mononucleotide (NMN) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2026-2031)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2026-2031)
4.2.3 Global Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Nicotinamide Mononucleotide (NMN) Application
5 Competition Landscape by Players
5.1 Global Nicotinamide Mononucleotide (NMN) Sales by Players (2020-2025)
5.2 Global Top Nicotinamide Mononucleotide (NMN) Players by Revenue (2020-2025)
5.3 Global Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024)
5.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Product Type & Application
5.7 Global Key Manufacturers of Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Company
6.1.1.1 North America Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025)
6.1.1.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025)
6.1.2 North America Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025)
6.1.3 North America Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025)
6.1.4 North America Nicotinamide Mononucleotide (NMN) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 China Market: Players, Segments, Downstream and Major Customers
6.2.1 China Nicotinamide Mononucleotide (NMN) Sales by Company
6.2.1.1 China Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025)
6.2.1.2 China Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025)
6.2.2 China Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025)
6.2.3 China Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025)
6.2.4 China Nicotinamide Mononucleotide (NMN) Major Customer
6.2.5 China Market Trend and Opportunities
6.3 Japan Market: Players, Segments, Downstream and Major Customers
6.3.1 Japan Nicotinamide Mononucleotide (NMN) Sales by Company
6.3.1.1 Japan Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2025)
6.3.1.2 Japan Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025)
6.3.2 Japan Nicotinamide Mononucleotide (NMN) Sales Breakdown by Type (2020-2025)
6.3.3 Japan Nicotinamide Mononucleotide (NMN) Sales Breakdown by Application (2020-2025)
6.3.4 Japan Nicotinamide Mononucleotide (NMN) Major Customer
6.3.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 GeneHarbor
7.1.1 GeneHarbor Company Information
7.1.2 GeneHarbor Business Overview
7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Products Offered
7.1.5 GeneHarbor Recent Development
7.2 Herbalmax
7.2.1 Herbalmax Company Information
7.2.2 Herbalmax Business Overview
7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Products Offered
7.2.5 Herbalmax Recent Development
7.3 Genex Formulas
7.3.1 Genex Formulas Company Information
7.3.2 Genex Formulas Business Overview
7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Products Offered
7.3.5 Genex Formulas Recent Development
7.4 Mirailab Bioscience
7.4.1 Mirailab Bioscience Company Information
7.4.2 Mirailab Bioscience Business Overview
7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Products Offered
7.4.5 Mirailab Bioscience Recent Development
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Company Information
7.5.2 Maac10 Formulas Business Overview
7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Products Offered
7.5.5 Maac10 Formulas Recent Development
7.6 EffePharm
7.6.1 EffePharm Company Information
7.6.2 EffePharm Business Overview
7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Products Offered
7.6.5 EffePharm Recent Development
7.7 Bontac
7.7.1 Bontac Company Information
7.7.2 Bontac Business Overview
7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Bontac Nicotinamide Mononucleotide (NMN) Products Offered
7.7.5 Bontac Recent Development
7.8 CELFULL
7.8.1 CELFULL Company Information
7.8.2 CELFULL Business Overview
7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Products Offered
7.8.5 CELFULL Recent Development
7.9 Kingdomway
7.9.1 Kingdomway Company Information
7.9.2 Kingdomway Business Overview
7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Products Offered
7.9.5 Kingdomway Recent Development
7.10 ABA Chemical
7.10.1 ABA Chemical Company Information
7.10.2 ABA Chemical Business Overview
7.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Products Offered
7.10.5 ABA Chemical Recent Development
8 Nicotinamide Mononucleotide (NMN) Manufacturing Cost Analysis
8.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
8.4 Nicotinamide Mononucleotide (NMN) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Nicotinamide Mononucleotide (NMN) Distributors List
9.3 Nicotinamide Mononucleotide (NMN) Customers
10 Nicotinamide Mononucleotide (NMN) Market Dynamics
10.1 Nicotinamide Mononucleotide (NMN) Industry Trends
10.2 Nicotinamide Mononucleotide (NMN) Market Drivers
10.3 Nicotinamide Mononucleotide (NMN) Market Challenges
10.4 Nicotinamide Mononucleotide (NMN) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer